Vanguard Group Inc ownership in BSFA / ANI Pharmaceuticals, Inc.

ANI 製藥公司

DE ˙ DB ˙ US00182C1036

€54.50 0.00 (0.00%)

2023-08-21
分享價格

Security	DE:BSFA / ANI Pharmaceuticals, Inc.
Institution	Vanguard Group Inc
Latest Disclosed Ownership	0 shares
Ownership	0.00%

2026-03-26 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of ANI Pharmaceuticals, Inc. (DE:BSFA). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-02-13 , Vanguard Group Inc had reported owning 1,288,972 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-03-26	2026-03-26	13G/A	1,288,972	0	-100.00	0.00	-100.00
2024-02-13	2024-02-13	13G		1,288,972		6.31

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-01-29	2025-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	1,305,068	27,598	2.16	103,022	-11.96	0.0015
2025-11-07	2025-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	1,277,470	116	0.01	117,016	40.40	0.0018
2025-08-11	2025-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	1,277,354	95,883	8.12	83,347	5.37	0.0013
2025-05-09	2025-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	1,181,471	-132,901	-10.11	79,099	8.86	0.0014
2025-02-11	2024-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	1,314,372	-33,739	-2.50	72,658	-9.66	0.0013
2024-11-13	2024-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	1,348,111	-92,333	-6.41	80,428	-12.32	0.0014
2024-08-13	2024-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	1,440,444	134,012	10.26	91,727	1.57	0.0018
2024-05-10	2024-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	1,306,432	17,460	1.35	90,314	27.07	0.0018
2024-03-11	2023-12-31	13F/A-1	ANI PHARMACEUTICALS	COM	00182C103	1,288,972	156,594	13.83	71,074	8.10	0.0016
2024-02-14	2023-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	1,288,972	156,594		71,074		0.0013
2023-12-18	2023-09-30	13F/A-1	ANI PHARMACEUTICALS	COM	00182C103	1,132,378	58,204	5.42	65,746	13.70	0.0016
2023-11-14	2023-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	1,132,378	58,204		65,746		0.0003
2023-08-14	2023-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	1,074,174	239,964	28.77	57,823	74.51	0.0014
2023-07-14	2023-03-31	13F/A-1	ANI PHARMACEUTICALS	COM	00182C103	834,210	21,586	2.66	33,135	1.36	0.0008
2023-05-15	2023-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	834,210	21,586		33,135		0.0008
2023-02-10	2022-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	812,624	24,701	3.13	32,692	29.09	0.0009
2022-11-14	2022-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	787,923	-26,251	-3.22	25,325	4.84	0.0007
2022-08-12	2022-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	814,174	38,875	5.01	24,157	10.85	0.0007
2022-05-13	2022-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	775,299	58,523	8.16	21,793	-34.02	0.0005
2022-02-14	2021-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	716,776	71,962	11.16	33,029	56.07	0.0007
2021-11-12	2021-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	644,814	25,489	4.12	21,163	-2.50	0.0005
2021-08-13	2021-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	619,325	-39,680	-6.02	21,706	-8.86	0.0005
2021-05-14	2021-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	659,005	55,783	9.25	23,816	35.95	0.0006
2021-02-12	2020-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	603,222	35,277	6.21	17,518	9.33	0.0005
2020-11-16	2020-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	567,945	18,505	3.37	16,023	-9.83	0.0005
2020-08-14	2020-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	549,440	-41,095	-6.96	17,769	-26.14	0.0006
2020-05-15	2020-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	590,535	14,305	2.48	24,058	-32.30	0.0010
2020-02-14	2019-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	576,230	-9,511	-1.62	35,536	-16.76	0.0012
2019-11-14	2019-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	585,741	21,424	3.80	42,689	-7.97	0.0016
2019-08-14	2019-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	564,317	12,859	2.33	46,387	19.25	0.0017
2019-05-15	2019-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	551,458	23,898	4.53	38,899	63.78	0.0015
2019-02-14	2018-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	527,560	4,747	0.91	23,751	-19.65	0.0011
2018-12-13	2018-09-30	13F/A-2	ANI PHARMACEUTICALS	COM	00182C103	522,813	8,173	1.59	29,559	-14.02	0.0012
2018-11-23	2018-09-30	13F/A-1	ANI PHARMACEUTICALS	COM	00182C103	522,813	0		29,559		0.0012
2018-11-14	2018-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	522,813	8,173		29,559
2018-08-14	2018-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	514,640	20,934	4.24	34,378	19.60	0.0014
2018-05-15	2018-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	493,706	12,477	2.59	28,744	-7.32	0.0013
2018-02-14	2017-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	481,229	6,400	1.35	31,015	24.44	0.0014
2017-11-14	2017-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	474,829	-2,119	-0.44	24,923	11.65	0.0012
2017-08-24	2017-06-30	13F/A-1	ANI PHARMACEUTICALS	COM	00182C103	476,948	35,722	8.10	22,322	2.18	0.0011
2017-08-11	2017-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	476,948	35,722		22,322
2017-05-12	2017-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	441,226	23,806	5.70	21,845	-13.67	0.0011
2017-02-14	2016-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	417,420	28,480	7.32	25,304	-1.95	0.0014
2016-11-14	2016-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	388,940	3,270	0.85	25,807	19.88	0.0015
2016-08-10	2016-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	385,670	15,760	4.26	21,527	72.89	0.0013
2016-05-13	2016-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	369,910	8,997	2.49	12,451	-23.55	0.0008
2016-02-08	2015-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	360,913	19,733	5.78	16,286	20.81	0.0011
2015-11-12	2015-09-30	13F/A-1	ANI PHARMACEUTICALS	COM	00182C103	341,180	-1,315	-0.38	13,481	-36.57	0.0006
2015-11-12	2015-09-30	13F/A-1	ANI PHARMACEUTICALS	COM	00182C103	341,180	-1,315		13,481		0.0006
2015-11-12	2015-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	7,273,373			285,239
2015-08-13	2015-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	342,495	45,287	15.24	21,253	14.32	0.0014
2015-05-15	2015-03-31	13F/A-1	ANI PHARMACEUTICALS	COM	00182C103	297,208	71,072	31.43	18,590	45.78	0.0013
2015-05-14	2015-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	297,208			18,590
2015-02-12	2014-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	226,136	1,765	0.79	12,752	100.98	0.0009
2014-11-12	2014-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	224,371	14,758	7.04	6,345	-12.11	0.0005
2014-08-11	2014-06-30	13F	ANI PHARMACEUTICALS	COM	00182C103	209,613	10,663	5.36	7,219	15.74	0.0006
2014-05-13	2014-03-31	13F	ANI PHARMACEUTICALS	COM	00182C103	198,950	91,256	84.74	6,237	188.48	0.0005
2014-02-12	2013-12-31	13F	ANI PHARMACEUTICALS	COM	00182C103	107,694	20,544	23.57	2,162	153.76	0.0002
2013-11-07	2013-09-30	13F	ANI PHARMACEUTICALS	COM	00182C103	87,150	87,150		852		0.0001

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.